Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Cymer, Inc. (CYMI)
Faruqi & Faruqi, LLP is investigating the Board of Directors of Cymer, Inc. (“Cymer” or the “Company”) (NASDAQ: CYMI) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to ASML Holding NV (“ASML”) (NASDAQ:ASML) in a cash-and-stock deal valued at about EUR 1.95 billion. Under the terms of the proposed transaction, Cymer’s stockholders will receive $20.00 in cash and a fixed ratio of 1.1502 ASML ordinary shares per each share of Cymer they own. The transaction values the proposed consideration at approximately $80.43 a share based on Monday’s close.
The investigation focuses on whether Cymer’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Cymer’s shares and by how much this proposed transaction undervalues the Company to the detriment of Cymer’s shareholders.
If you own common stock in Cymer and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.